Delirium in Children Undergoing Stem Cell Transplantation

NCT04937400 · tracked via the Priya Life Science Canada tracker

Sponsor

Weill Medical College of Cornell University

Phase

Observational

Started

2021-07-12

Last updated

2025-11-14

Condition(s) studied

Stem Cell Transplant ComplicationsDelirium

Investigational drug(s) / intervention(s)

Daily screening for delirium

Daily screening for delirium: Each child will be screened twice daily for delirium throughout the transplant hospitalization

Study summary

Children undergoing stem cell transplants are at risk for delirium, a temporary change in thinking and behavior. This study will define delirium rates, risk factors, and outcomes. Our eventual goal is to reduce delirium in this population.

Eligibility

Sex

ALL

Min age

—

Max age

21 Years

Healthy volunteers

Inclusion Criteria: * Age 0-21 years old * Admitted for purpose of stem cell transplant Exclusion Criteria: * Age \>21 years old * Admitted for reason other than stem cell transplant (example: late post-transplant complications).

Primary outcome measure(s)

Delirium incidence — 1-50 days
Number of patients who develop delirium during the course of their transplant hospitalization

Trial sites (6)

Facility	City	Region
University of California San Francisco	San Francisco	California
Dana Farber Cancer Center	Boston	Massachusetts
Weill Cornell Medical College	New York	New York
Children's Hospital of Philadelphia	Philadelphia	Pennsylvania
St Jude Children's Research Hospital	Memphis	Tennessee
Hospital for Sick Children	Toronto	Ontario

More Weill Medical College of Cornell University trials in Canada

STICH3C Cardiac Magnetic Resonance Observational Study Recruiting

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women Recruiting

Randomization of Single vs Multiple Arterial Grafts Recruiting

One-Month DAPT in CABG Patients Recruiting

Other trials for the same condition

Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor Recruiting

Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients Recruiting

Neurocognitive Outcomes for ICU Patients With Acute Kidney Injury Recruiting

Melatonin for Treatment of Delirium in Critically Ill Adult Patients Recruiting

CTSN Embolic Protection Trial Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04937400 on ClinicalTrials.gov ↗ ← All trials in Canada